.
MergerLinks Header Logo

New Deal


Announced

Completed

InTandem Capital Partners completed the investment in Adams Clinical.

Synopsis

InTandem Capital Partners, a healthcare services focused private equity firm, completed the investment in Adams Clinical, a clinical trial site network with locations across the Northeast that conducts independent evaluations of drugs to treat psychiatric and neurologic illnesses. Financial terms were not disclosed. "We are excited to have InTandem Capital’s help growing Adams. We value InTandem’s integrated investment and operating strategy, which is tailored for companies like ours at an inflection point. The InTandem team’s wealth of industry knowledge will enable us to develop a world-class site network that benefits both our pharmaceutical company customers and the patients who ultimately are prescribed drugs we tested," Nelson Rutrick, Adams Clinical CEO.

Show Details & Financials

Market Context

Search a database of more than 250,000 verified dealmakers

Receive automated updates on global transactions

Follow the activity, relationships and transactions of top dealmakers

No credit card required

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US